These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pioglitazone/glimepiride (Duetact) for diabetes. Med Lett Drugs Ther; 2007 Jan; 49(1253):9-11. PubMed ID: 17261966 [No Abstract] [Full Text] [Related]
5. Treating type 2 diabetes: targeting the many causative factors. Sutherland JE; Hoehns JD J Fam Pract; 2004 May; 53(5):376-88. PubMed ID: 15125823 [No Abstract] [Full Text] [Related]
6. Drugs for type 2 diabetes. Treat Guidel Med Lett; 2008 Jul; 6(71):47-54. PubMed ID: 18583949 [No Abstract] [Full Text] [Related]
7. Reduction in use of healthcare services with combination sulfonylurea and rosiglitazone: findings from the Rosiglitazone Early vs SULfonylurea Titration (RESULT) study. Herman WH; Dirani RG; Horblyuk R; O'Neill MC; Kravitz B; Heise MA; Bakst A; Freed MI; Am J Manag Care; 2005 Apr; 11(4):273-8. PubMed ID: 15839187 [TBL] [Abstract][Full Text] [Related]
8. Adherence to a fixed-dose combination of rosiglitazone/glimepiride in subjects switching from monotherapy or dual therapy with a thiazolidinedione and/or a sulfonylurea. Thayer S; Arondekar B; Harley C; Darkow TE Ann Pharmacother; 2010 May; 44(5):791-9. PubMed ID: 20371759 [TBL] [Abstract][Full Text] [Related]
10. Pioglitazone with sulfonylurea: glycemic and lipid effects in Taiwanese type 2 diabetic patients. Tseng CH; Huang TS Diabetes Res Clin Pract; 2005 Nov; 70(2):193-4. PubMed ID: 16188579 [No Abstract] [Full Text] [Related]
11. Oral combination therapy with thiazolidinediones and sulfonylureas in type 2 diabetes. Charbonnel B Int J Clin Pract Suppl; 2007 Jun; (153):1-2. PubMed ID: 17594387 [No Abstract] [Full Text] [Related]
12. Insulin initiation in Type 2 diabetes. Page S Diabet Med; 2005 Sep; 22 Suppl 4():2-5. PubMed ID: 16109011 [No Abstract] [Full Text] [Related]
13. Pioglitazone/metformin (Actoplus met). Med Lett Drugs Ther; 2006 Jan; 48(1227):9-11. PubMed ID: 16444136 [No Abstract] [Full Text] [Related]
15. The therapeutic efficacy of rosiglitazone is enhanced in sulphonylurea-treated patients with type 2 diabetes. Itakura H; Abbasi F; Lamendola C; Basina M; Reaven G Diabetes Obes Metab; 2008 Aug; 10(8):685-7. PubMed ID: 18476981 [No Abstract] [Full Text] [Related]
17. Pioglitazone plus glimepiride: a promising alternative in metabolic control. Derosa G Int J Clin Pract Suppl; 2007 Jun; (153):28-36. PubMed ID: 17594391 [TBL] [Abstract][Full Text] [Related]
18. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted? Standl E; Schnell O Diabetes Care; 2008 Feb; 31 Suppl 2():S136-9. PubMed ID: 18227474 [No Abstract] [Full Text] [Related]
19. Which oral drug is right for your type 2 diabetes? New thinking on oral drug combinations that can provide better glycemic control. Health News; 2005 Feb; 11(2):10-1. PubMed ID: 15732153 [No Abstract] [Full Text] [Related]
20. Glimepiride for NIDDM. Med Lett Drugs Ther; 1996 May; 38(975):47-8. PubMed ID: 8632731 [No Abstract] [Full Text] [Related] [Next] [New Search]